Tech Company Financing Transactions
Progenity Funding Round
On 8/19/2016, Progenity landed $12 million in funding from private investors.
Transaction Overview
Company Name
Announced On
8/19/2016
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 1 investor participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
5230 S. State Rd.
Ann Arbor, MI 48108
USA
Ann Arbor, MI 48108
USA
Phone
Website
Email Address
Not Recorded
Overview
Progenity (Nasdaq: PROG) is a CLIA-accredited laboratory and is accredited by the College of American Pathologists (CAP). We operate across the United States.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Harry Stylli
Chief Financial Officer
Eric d'Esparbes
Chief Information Officer
Troy Seelye
Chief Operating Officer
Damon Silvestry
Chief Scientific Officer
Matthew Cooper
VP - Bus. Development
Sami Shihabi
Browse more venture capital transactions:
Prev: 8/17/2016: Rubrik venture capital transaction
Next: 8/19/2016: Camino Financial venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs